Trial Search Results
Lymphedema Study for Arm or Leg Lymphedema
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Stanford is currently accepting patients for this trial.
- Drug: Ketoprofen
- Drug: Placebo
- a history of lymphedema of one or more limbs (unilateral or bilateral), with a
duration of > 6 months.
- Patients with active cancer, infection or bleeding tendency will be excluded.
- We will also exclude patients with medical contraindications to NSAIDs, including
history of allergies, know gastrointestinal intolerance, or other serious systemic
illness (e.g., renal failure, hepatic dysfunction, congestive heart failure,
neurological or psychological impairment) that would impair the patients' ability to
- Minors (<18 years of age) *>90 years of age
Ages Eligible for Study
18 Years - 90 Years
Genders Eligible for Study